Integrating multidisciplinary approaches from immunology, molecular biology, and clinical medicine will facilitate the translation of IL-37-related discoveries into clinical practice, providing novel strategies for the prevention and treatment of respiratory diseases, and ultimately improving patient outcomes. This evidence concerns the gene IL37 and respiratory system disorder.